Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.
Saved in:
| Title: | Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. |
|---|---|
| Authors: | Hantel A; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA. andrew_hantel@dfci.harvard.edu., Luskin MR; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Khan I; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Warner E; Center for Bioethics, Harvard Medical School, Boston, MA., Patel AA; Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Walsh TP; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Lathan CS; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Abel GA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA. |
| Source: | Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1046-1052. Date of Electronic Publication: 2024 Apr 01. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
